Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The STD testing devices market is experiencing a notable trend towards at-home testing solutions. Increased awareness of sexual health, coupled with the convenience and privacy offered by at-home testing kits, has led to a surge in their popularity. This trend reflects a shift in consumer preferences towards self-administered tests for sexually transmitted diseases.
Trends are apparent throughout the market of STD testing devices all majorly due to the developments in the technology. The growth of technologies that are both rapid and highly-sensitive for STD diagnostics; such as nucleic acid amplification tests (NAATs) aids in better speed and accuracy of STD diagnosis, facilitating immediate action.
Multiplex testing that allows screening for more than one STD in a single test is becoming popular. This direction meets the requirement of universal panel screening, especially in the populations prone to multiple diseases. Efficiency, cost saving, early diagnosis and treatment are all captured by multiplex testing.
The responsiveness of the rapid development of North American-based testing kits for STD to the LGBTQ++’s inclusivity and by promoting the devices a wider market in other countries through advertisement. The relevant trend focuses on customizing testing solutions to fit the unique demands and fears of the LGBTQ+ community. The inclusivity is highly crucial for provision of contextually appropriate and culture-sensitive testing alternatives.
The introduction of telehealth services has changed the face of the STD testing, radically. Online consultation, test kit delivery, and result reporting are soon becoming part of the established telehealth platforms that allow testing even when a global health crisis takes place making remote healthcare solutions a necessity.
A recent trend is the collaboration of manufacturers with the retail or online platforms. With the distribution of STD testing devices through pharmacies to e-commerce platforms and across retail outlets, manufacturers are making availability easier for a wider consumer base, reduce stigma, and encourage frequent testing.
This is done to emphasize on friendly designs for devices STD testing. They help in the simplified sample collection processes, clear instructions, and easy interpreted results which contributes to better user experience. The objective of this trend is to ensure that as many people as possible are proactively taking charge of regular testing; this would promote a proactive approach to sexual health.
The inadequacy in regular STD testing on the part of patients has not gone unnoticed by the market; rather campaigns and educational measures that promote this type of testing are growing by the day. In terms of the global anti-stigma campaigns efforts, stigma reduction campaigns both online and educational programs, targeting eradication of stigma, increase of knowledge on STDs and improvement of the sexual culture of responsible practices.
The direction towards the global health more specifically against the spread of STDs in the global-wideness has been developing under tremendous efforts. The efforts at the global level see international organizations, governments, and nonprofits working to make testing equipment more available, especially in high prevalence regions, influencing a unified undertaking to overcome sexually transmitted infections.
The integration of artificial intelligence is emerging as a trend in the STD testing devices market. AI algorithms are being employed for data analysis, result interpretation, and risk assessment. This not only enhances the accuracy of diagnosis but also contributes to personalized risk assessments and recommendations for preventive measures.
STD Testing Devices Market Highlights:
STD Testing Devices Market
The STD Testing Devices Market is projected to reach USD 23.3 Billion by 2032 at 5.5% CAGR during the forecast period 2023-2032.
Market Synopsis
Sexually transmitted disease (STDs) is an infection caused due to some organisms. STDs can be transmitted from one person to another through sexual activity and intimate contact. The cases of sexually transmitted diseases keep climbing among 45 and older Americans. 82,938 cases of gonorrhea, syphilis, and chlamydia were reported among 45 and older Americans in the year 2016.
Market Influencer
The increasing prevalence of lifestyle diseases, rising geriatric population along with increasing awareness about sex-related diseases is influencing the market growth positively. The increasing number of product launches by key players in the market are likely to act as a promising factor for the increase in the near future. For Instance, Quest Diagnostics launched three new sexually transmitted disease (STD) laboratory test packages that individuals can purchase online for some of the most prevalent STDs in the United States.
Market Drivers
- Increase in prevalence of sex-related diseases
- Every year, 376 million new cases of chlamydia, syphilis, gonorrhea, and trichomoniasis are reported globally. The total estimated direct cost of STIs annually in the U.S. is about USD 16 billion.
- The most common STIs affecting a lot of people are Chlamydia, gonorrhea, and syphilis. Approximately 1.5 million cases of chlamydia were reported in 2015 in US alone which represents it to be the highest number of annual cases of any condition ever reported.
- A total of 89,239 cases of gonorrhea were reported by 27 states of the European Union in 2017.
- Increasing prevalence of lifestyle diseases
- Rise in healthcare expenditure
- Increasing geriatric population
- Increasing mergers & acquisitions by prominent players in the market
- For instance, in 2019, the US Food and Drug Administration (FDA) has cleared two tests "The Aptima Combo 2 Assay (Hologic Inc) and the Xpert CT/NG (Cepheid)" to detect Chlamydia trachomatis and Neisseria gonorrhoeae from throat and rectum samples.
- Increasing awareness about STIs
Market Restraints
- Lack of information about the symptoms and causes is hampering the growth of the market.
STD Testing Devices Market Segmentation
By Type
- Laboratory Devices: It is expected to hold a larger share. Laboratory devices are the traditional methods of detecting STI and a large number of hospitals and clinics are expected to be using the laboratory devices.
- Point of Care (POC) Devices: It is expected to be the fastest-growing segment as it is less time-consuming.
By End-User
- Hospitals and Clinics: Hospitals and clinics segment dominates the global market for The positive growth of hospitals is attributed to factors such as high volume of STD tests performed in hospital-based laboratories across the globe and growing patient population.
- Diagnostic Laboratories: Diagnostic Laboratories segment take up the second-largest share due to the rising number of diagnostic labs and the increasing patient population.
- Research Laboratories and Institutes: segment is projected to be the fastest-growing segment over the assessment period. The research and development activities with respect to STD diagnostics and treatment have increased in last decade which has resulted in the growing demand for the devices and kits in the R&D facilities. Besides that, government funding for the research and development for effective treatment of STD has pushed the growth of this segment. The researchers from King's College London, have published a study in Nature Communications, according to them skin vaccination can generate protective CD8 T-cells that are recruited to the genital tissues and could be used as a vaccination strategy for sexually transmitted infections (STIs).
By Region
- Americas: It is the largest regional market owing to the factors such as large patient population, rise in prevalence of STIs, the availability of a wide variety of STD testing kits and surges in awareness about the causes of STIs and its treatments which are driving the growth of the market in this region.
- According to the Centers for Disease Control and Prevention (CDC), more than 1300 cases of congenital syphilis, about 40% increase was reported in newborns during 2017-2018 in US. Similarly, a rise in 8487 new cases of women suffering from gonorrhea in US alone was reported during the year 2017-2018.
- Europe: The key factors driving the market growth are the growing research and development support by government bodies for the healthcare sector, and the significant demand for STI testing is driving the growth of the STI testing devices market in Europe. Additionally, the rising initiatives by organizations are driving market growth. For Instance, EuroTEST initiative is a platform for information exchange and activities to improve early diagnosis and care of HIV, viral hepatitis, sexually transmitted infections, and tuberculosis.
- Asia-Pacific: The Asia-Pacific region is anticipated to be the fastest-growing region in the global STI testing devices market. The rising patient population is driving the growth of the Asia-Pacific STI testing devices market. Additionally, increasing disposable income of the middle-class population, and improving healthcare infrastructure in emerging countries such as China and India are driving the market growth. However, unfavorable healthcare reforms may restrain the growth of the market to some extent.
- Middle East & Africa: This region is the smallest market due to limited healthcare infrastructure and limited exposure to technological advancements.
Key Players
- Abbott (US)
- MedMira Inc. (Canada)
- bioMeriuex (France)
- Qaigen Inc. (US)
- Thermo Fisher Scientific (US)
- Cepheid (Danaher Corporation) (US)
- Hoffmann-La Roche AG (Switzerland)
- Diasorin S.p.A (Italy)
- Bio-Rad Laboratories, Inc. (US)
- Becton Dickinson and Company (US)
- Hologic, Inc. (US)
- GenePOC Inc. (Canada)
- Meridian Bioscience (US)
- OraSure Technologies (US)
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
